Results 91 to 100 of about 1,414,634 (195)
A Case of Systemic Sclerosis Sine Scleroderma Presenting as Pulmonary Interstitial Fibrosis
Lung involvement in systemic sclerosis(SSC) is common but usually occurs late in the course. Skin changes usually occur before the pulmonary findings. In this report, a patient who developed pulmonary interstitial fibrosis without skin changes is presented. A diagnosis of SSC lung involvement was made histologically.
Jin Ho Kwak +9 more
openaire +1 more source
Abstract Background and Aims Systemic sclerosis (scleroderma; SSc) patients can develop pulmonary arterial hypertension (PAH), which is a leading cause of death. We sought to evaluate severity, therapeutic strategy and survival of SSc‐PAH in the Australian Scleroderma Cohort Study (ASCS).
Zoe Brown +13 more
wiley +1 more source
Assessing the quality of end‐of‐life care in systemic sclerosis
Abstract Background Systemic sclerosis (SSc) is a rare autoimmune disease with the highest mortality among rheumatic diseases, yet little is known about the quality of end‐of‐life care in SSc. Aims To evaluate end‐of‐life care in SSc against the Australian National Consensus Statement's Essential Elements for high‐quality end‐of‐life care and compare ...
Julie McDonald +4 more
wiley +1 more source
ABSTRACT Aims This systematic review assesses current evidence on the management of non‐plaque (dental biofilm)‐induced gingival diseases and conditions (NPIGDs), including (i) inflammatory and immune conditions, (ii) neoplasms and (iii) gingival pigmentations.
Maria Clotilde Carra +5 more
wiley +1 more source
Background Systemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy and progressive fibrosis. Reduced muscle mass is common and contributes to myopenia, sarcopenia and adverse clinical outcomes.
Lucas Denardi Dória +15 more
doaj +1 more source
Female genital lichen sclerosus
This review provides a comprehensive overview of clinical presentation and emerging evidence supporting a predominantly immune‐mediated pathogenesis characterized by Th1‐skewed inflammation, epithelial dysfunction and progressive fibrosis. Contributory factors including the emerging role for occlusive exposure of susceptible epithelium to urine are ...
Ashley Spencer, Sandra Jerkovic Gulin
wiley +1 more source
Restoring Mouth Opening in Systemic Sclerosis: A Scoping Review of Interventions
ABSTRACT Objectives To map and characterize the therapeutic strategies described in the literature for the management of microstomia in patients with systemic sclerosis. Methods This scoping review was conducted in accordance with the PRISMA‐ScR guidelines. Searches were performed in Medline/PubMed, Embase, Scopus, Web of Science, Cochrane Library, and
Beatriz Borba Barros Bernardo +5 more
wiley +1 more source
Rapidly progressive course of systemic sclerosis sine scleroderma: a case report and short literature review [PDF]
Systemic sclerosis (SSc) is an autoimmune disease that affects the connective tissue. It is progressive and characterized by a diverse course, resulting in a heterogeneous clinical picture.
Palka, Klaudia; Department of Internal Medicine, Rheumatology and Clinical Immunology, Medical University of Silesia, Katowice, Poland +7 more
core +1 more source
ABSTRACT Early, inflammatory morphea can rarely mimic an acquired capillary malformation (CM), and emerging evidence suggests that endothelial injury may precede fibrosis in morphea, with vascular abnormalities driving immune recruitment and fibroblast activation.
Hannah Kolarik +7 more
wiley +1 more source
Systemic sclerosis, also called scleroderma, is an immune-mediated rheumatic disease that is characterised by fibrosis of the skin and internal organs and vasculopathy.
Khanna, D, Denton, CP
core +1 more source

